je.st
news
Amgen, Inc. (AMGN) Upgraded at Morgan Stanley
2015-12-15 02:20:07| Biotech - Topix.net
The firm currently has a $193.00 price target on the medical research company's stock, up from their previous price target of $160.00. Morgan Stanley's price objective indicates a potential upside of 22.07% from the company's previous close.
Tags: morgan
stanley
upgraded
amgen
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||